Skip to main content

Microsoft and a Seattle biotech are seeking 1,000 volunteers to give blood for a virtual coronavirus study. Here's how you can enroll and make up to $250.

* The technology giant Microsoft is working with a Seattle-based biotech to better understand the wide range of immune responses to the novel coronaviruses.  * The duo are recruiting 1,000 US-based volunteers to enroll in a virtual trial. Eligible people have to live near certain metro areas and have to have been exposed to the virus, infected with it, or recently recovered from it. * Applying for the study can be done completely online by answering some basic questions. Selected participants will have their blood drawn at their home. * The data could help better understand some of the mysteries around the coronavirus, particularly why some people have barely any symptoms while others end up critically ill.  * Visit Business Insider's homepage for more stories. A new study is aiming to help figure out why the coronavirus affects people in such drastically different ways.  Some infected people have no symptoms, while others wind up critically ill and requiring weeks of oxygen support in a hospital. The tech giant Microsoft has launched a study with the Seattle-based biotech Adaptive Biotechnologies to better understand the wide range of immune responses to the virus.  The two companies are recruiting 1,000 volunteers for a virtual study. Eligible participants have to be located in one of about two dozen metro areas across the US, and to have been exposed to, infected with, or recovered from the novel coronavirus.  Read more: Microsoft is teaming up with a $5 billion Seattle biotech to unravel the mystery of how the immune system responds to the coronavirus, and it could lead to new treatments and tests The researchers are specifically focusing on T-cell responses, which are a critical element of the body's immune response. T cells help fight the virus, and long-lasting cells may help build immunity to future infections.  Following the explosion of antibody tests and research, Microsoft and Adaptive are hoping this research can build a "third pillar" of COVID-19 testing focused on T cells, said Lance Baldo, Adaptive's chief medical officer.  Enrollment is open now and is done online The study is open to people living within 60 miles of 23 different metro areas across the US, including Los Angeles, Boston, New York, and Houston.   The study has already enrolled more than 100 people across the three eligible groups of exposed, infected, and recovered people. To qualify for the exposed group, you need to either live with someone that has a confirmed case of COVID-19 or be a healthcare worker treating sickened patients without protective gear.  Infected COVID-19 patients are required to have a confirmed diagnosis, either through a positive test result or a diagnosis from a healthcare provider. Never miss out on healthcare news. Subscribe to Dispensed, Business Insider's weekly newsletter on pharma, biotech, and healthcare. People meeting those criteria can enroll online by filling out a questionnaire. If selected, researchers will arrange for a phlebotomist to come to you to draw blood samples. The technician will be wearing protective equipment and will also conduct or throat or nasal swab.  The study is offering $50 gift cards to those who complete the initial study. Researchers are also giving participants the option to participate in up to four additional blood draws over a two-month period. Participants completing all five blood draws could earn $250 in gift cards.  While the money may be a nice incentive, the research could help decode some of the mysteries about the coronavirus. Microsoft and Adaptive have pledged to make the data and findings freely available.  Initial results could come as soon as June, Adaptive's Baldo said. For more information, go to immunerace.com.  Join the conversation about this story » NOW WATCH: How the Navy's largest hospital ship can help with the coronavirus
https://bit.ly/2LoA0we

Popular posts from this blog

All the coolest features of every Tesla vehicle ever made or unveiled, ranked (TSLA)

* Tesla's vehicles are and always have been crammed with great ideas. * These range from touchscreen interfaces to innovative battery designs to staggering acceleration. * I've driven or experienced every vehicle Tesla has ever sold or intends to sell in the future. * Here are all my favorite features, ranked. * Visit Business Insider's homepage for more stories. In about two decades, Tesla has done what everyone in the auto industry thought was impossible: create an all-electric brand that could sell hundreds of thousands of vehicles. Tesla could have done that in a boring or modest way, developing  the equivalent of an electric VW Beetle. Instead, Tesla made fantastically compelling cars that are fast, look amazing, and are packed with features. Here's a rundown of all my favorites, ranked from bottom to top: FOLLOW US: On Facebook for more car and transportation content! Tesla has been in business for 17 years. In that period of time, it's consisten...

Inside the fight between my small Iowa hometown and a $12 billion utility over smart meters and the radiation that some residents call 'poison'

* Many residents in Fairfield, Iowa, home to thousands of disciples of a deceased Indian guru, claim that radiation emitted by cell phones and other devices is harmful to human health.  * Those beliefs created a problem for a local utility that began deploying radiation-emitting smart meters in 2017. * Through administrative proceedings, Fairfield residents fought back against the utility's smart meter program — and, for the most part, won.  * At its core, the fight wasn't about the health effects of smart meters. It was about the freedom to exercise a set of beliefs, as unusual as they may be. * Visit Business Insider's homepage for more stories. FAIRFIELD, IOWA — I was standing outside my childhood home on an unseasonably warm spring day when I saw my neighbor approaching from across the street.  It was May, and I had been staying with my parents months after escaping New York City. In their home, more than 80 miles away from the nearest airport, the threat of a pa...

Here's an exclusive look at the pitch deck London fintech Lanistar used to raise $19 million at a $190 million valuation

* London-based fintech startup Lanistar has raised a £15 million ($19 million) funding round from Milaya Capital.  * Founded in 2019, Lanistar is building a personal financial management platform that will launch later in 2020.  * "We're expecting a huge amount of growth upon our launch and have already seen strong interest among our sign ups," Gurhan Kiziloz, founder and CEO of Lanistar, told Business Insider. * Visit Business Insider's homepage for more stories.  The coronavirus lockdown in the UK has brought the importance of managing money into sharp relief. A recent study from Money.com shows that 71% of UK households have saved cash during lockdown, and, with uncertainty about jobs and the economy looming, money management is now front of mind for many. Lanistar, a banking platform with a focus on personal finance, is one company offering tools for consumers to better manage their money. It has just raised a £15 million ($19 million) funding round from Mil...